Aptanomics SA
www.aptanomics.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Aptanomics SA
Investing in French Biotech--When It's Not Too French
Neuro 3d's €31.5 million third round late in 2004 was one of France's largest private biotech financings for years. But none of the investors are looking to France to provide the exit opportunities, which are more likely to be found in M&A, or in Switzerland.
Investing in French Biotech--When It's Not Too French
Neuro 3d's €31.5 million third round late in 2004 was one of France's largest private biotech financings for years. But none of the investors are looking to France to provide the exit opportunities, which are more likely to be found in M&A, or in Switzerland.
Aptanomics SA
French start-up Aptanomics is using peptide aptamers to validate novel intracellular targets.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice